Ceramides

Ceramides make up about half of the lipid “mortar” between corneocytes. Together with cholesterol and free fatty acids they form the lamellar membranes that limit Transepidermal Water Loss. Ceramide levels are reduced in Atopic Dermatitis skin. The enzymes that make ceramides (β-glucocerebrosidase and acid sphingomyelinase) work best at acidic pH, so a rise in Skin pH also cuts ceramide production (Panther & Jacob 2015; Elias & Wakefield 2011). Ordinary occlusive emollients such as paraffin coat the skin but do not replace the missing lipid. Ceramide-dominant, “physiological lipid” creams were designed to fill that gap, usually with ceramides, cholesterol and fatty acids in a near-physiological ratio (Chamlin et al. 2002).

Ceramides [part-of] skin barrier Skin Barrier Dysfunction [relates] Ceramides Skin pH [regulates] Ceramides Ceramides [prevents] Transepidermal Water Loss

Paediatric trials. Several trials have tested ceramide creams in children:

  • Chamlin et al. (JAAD 2002): 24 children with stubborn eczema swapped their usual moisturiser for a ceramide-dominant emollient and kept their other treatment. SCORAD improved in 22 of 24 by 3 weeks, TEWL fell, and lamellar membranes reappeared on electron microscopy. There was no control group.
  • Ma et al. (Adv Ther 2017): an investigator-blinded RCT in 64 Chinese children aged 2–12 after steroid clearance. A ceramide moisturiser plus body wash delayed the median time to flare to 89 days, compared with 27 days for body wash alone, and 50% vs 72% had flared by 12 weeks. The comparator was no moisturiser, not a standard one, and the trial was funded by the manufacturer (Galderma).
  • Gupta et al. (Pediatric Dermatology 2023): a double-blind RCT in 53 children (mean age 8.2) with mild-to-moderate eczema, the cleanest head-to-head test. A paraffin-based moisturiser and a ceramide-based moisturiser gave similar SCORAD falls at 3 months (21.4 vs 22.1, p = 0.37). Quality of life, TEWL, steroid use and time to remission were also similar.

Ceramides [treats] Atopic Dermatitis Ceramides [relates] Mineral Oil Ceramides [relates] SCORAD

Systematic evidence versus standard emollients. A 2023 meta-analysis of five small RCTs (15–38 participants each, mixed ages, Indonesia, Thailand and Germany) found a statistically significant but tiny SCORAD advantage for ceramide moisturisers (mean difference −0.98, 95% CI −1.63 to −0.33; 2 studies, 106 patients). It found no significant TEWL difference (MD −3.56, p = 0.17; I² = 90%). The comparators varied widely, including 5% urea, petrolatum, aloe vera and placebo (Nugroho et al. 2023). The 2017 Cochrane review found no reliable evidence that any moisturiser beats another. The BEE Trial (2022) found that emollient type (lotion, cream, gel or ointment) made no difference in children aged 6 months to 12 years, so acceptability should guide the choice.

Cochrane [contradicts] Ceramides BEE Trial [relates] Ceramides

Conflict: [Nugroho et al., Indian J Dermatol 2023] concludes that ceramide moisturisers “are more effective at improving AD severity” than other moisturisers (SCORAD MD −0.98). [Gupta et al., Pediatr Dermatol 2023] found a ceramide moisturiser and a paraffin moisturiser comparable in children (SCORAD change 22.1 vs 21.4, p = 0.37). [Cochrane 2017] found no moisturiser reliably better than another. Unresolved. A ~1-point SCORAD difference is unlikely to be clinically meaningful. Added to open_questions.

Where ceramides do help: tolerability. Ceramide creams have a clearer advantage in comfort than in efficacy. In a blinded split-arm RCT in 42 children aged 8–16 with excoriated eczema, a ceramide cream stung less than 5% urea cream (VAS 0.69 vs 1.43, p = 0.035) (Ho et al. 2020). For toddlers with raw or scratched patches, a cream that does not sting makes regular Emollient Therapy and Soak and Seal easier to keep up.

Ceramides [opposes] Urea Creams Ceramides [supports] Emollient Therapy

Cost. None of the sources reviewed this round gave a direct price comparison. Branded ceramide creams are generally sold as cosmetic or over-the-counter products. Because the paediatric head-to-head trial found plain paraffin emollients comparable, cheaper paraffin-based emollients remain a reasonable first choice (Gupta 2023). Ceramide creams are an option when stinging or acceptability is the problem. Ho et al. (2020) note that parents weigh irritation, greasiness and cost when choosing a moisturiser.

What parents report (evidence: anecdotal). Ceramide-containing creams (mostly CeraVe) are among the products US parents mention most. Parents relay dermatologists recommending them because “Cerave has several ceramides that your skin needs”, and one parent describes the turning point as covering a baby “in cerave then put a thick layer of Aquaphor on the top. She’s SMILING” (r/Parenting; r/beyondthebump). Parents credit the amount and the sealing layer as much as the ingredient. See Parent Experiences.

Ceramides [relates] Parent Experiences

Connections

  • Natural Moisturising Factor — lactate (an NMF component) may stimulate ceramide synthesis; ceramide cream less irritating than urea, source: Practical Dermatology; Ho 2020
  • Transepidermal Water Loss — ceramide-dominant emollient lowered TEWL in children, source: Medscape
  • Urea Creams — ceramide cream stung less than 5% urea in children, source: Ho et al. 2020
  • Skin pH — acidic pH needed for ceramide-producing enzymes, source: Panther & Jacob 2015
  • Mineral Oil — paraffin moisturiser comparable to ceramide in paediatric RCT, source: Gupta 2023
  • BEE Trial — emollient type does not change outcome in children, source: Ridd 2022
  • Cochrane — no moisturiser reliably better than another, source: van Zuuren 2017
  • Emollient Therapy — ceramide creams are one emollient option, source: Nugroho 2023
  • Parent Experiences — parent reports (anecdotal), source: round-10 forum threads